Citation Information :
Preeclampsia Screening: Combining All the Right Markers to predict a Wrong Disease?. Donald School J Ultrasound Obstet Gynecol 2016; 10 (4):367-371.
Wataganara T. Preeclampsia Screening: Combining All the Right Markers to predict a Wrong Disease? Donald School J Ultrasound Obstet Gynecol 2016;10(4):367-371
Management guidelines for preeclampsia. Siriraj Hosp Gaz 2004;56:604-616.
Preeclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 2013 Nov;347:f6564.
Maternal and neonatal outcomes in women with severe pre-eclampsia undergoing cesarean section: a 10-year retrospective study from a single tertiary care center: anesthetic point of view. J Matern Fetal Neonatal Med 2016 Dec;29(24):1-5.
Management of preeclampsia in preterm pregnancy. Siriraj Med J 2005 Oct;57(10):427.
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn 2014 Jul;34(7):642-648.
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia. Ann of Intern Med 2014 Oct;161(8):613.
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011 Jan;31(1):66-74.
Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013 Nov;128(19):2121-2131.
Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 2012;7(11):e50208.
Early prediction of preeclampsia. Obstet Gynecol Int 2014;2014:297397.
How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2011 Jun;90(6):564-573.
Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet Gynecol Scand 2011 Jun;90(6):574-585.
Identification and management of high-risk pregnancies. Siriraj Med J 2006;58:982-983.
Maternal body mass index at term does not predict the severity of preeclampsia. J Med Assoc Thai 2008 Aug;91(8):1166-1171.
Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008 Aug;32(2):138-146.
Twostage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004 Mar;190(3):707-713.
[Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam 1968 Oct;65(4):281-393.
World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004 Dec;104(6):1367-1391.
Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Eng J Med 2016 Jan;374:13-22.
